ICPT

Intercept Pharmaceuticals News

Company Name Stock Ticker Symbol Market Type
Intercept Pharmaceuticals Inc ICPT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.19 1.35% 14.25 12:09:36
Open Price Low Price High Price Close Price Prev Close
14.23 13.72 14.30 14.06
more quote information »

Recent News

Date Time Source Heading
10/06/20227:21IHNWFeaturedElectromedical Update: Strong Q3 Sales Momentum, New Financing , Improved Supply Chain, Expanding Product Development and Production.
10/03/202221:45TRMNIntercept Pharma (ICPT) Receives a Hold from RBC Capital
9/30/202216:15TRMNIntercept Pharma (ICPT) Receives a Buy from Needham
9/30/202216:15TRMNIntercept Pharma (ICPT) Receives a Hold from JMP Securities
9/30/202216:11TRMNAnalysts Have Conflicting Sentiments on These Healthcare..
9/30/202208:01EDGARCurrent Report Filing (8-k)
9/30/202207:55GLOBEIntercept Pharmaceuticals Announces REVERSE Phase 3 Study of..
9/22/202203:05TRMNB.Riley Financial Reaffirms Their Buy Rating on Intercept..
9/21/202207:31EDGARCurrent Report Filing (8-k)
9/21/202207:30GLOBEIntercept Pharmaceuticals Announces Summary of Key Actions..
9/21/202200:25TRMNJMP Securities Remains a Hold on Intercept Pharma (ICPT)
9/20/202216:02EDGARCurrent Report Filing (8-k)
9/20/202212:45GLOBEImproved Transplant-Free Survival Observed with Obeticholic..
9/16/202216:03EDGARStatement of Changes in Beneficial Ownership (4)
9/12/202207:31EDGARCurrent Report Filing (8-k)
9/08/202217:01EDGARCurrent Report Filing (8-k)
9/07/202208:00GLOBEIntercept Pharmaceuticals to Conduct Fireside Chats and..
9/07/202207:31EDGARCurrent Report Filing (8-k)
9/06/202216:02EDGARStatement of Changes in Beneficial Ownership (4)
9/02/202216:59EDGARAmended Statement of Ownership (sc 13g/a)
9/02/202208:47DJNIntercept Pharmaceuticals Retires Additional Senior Notes
9/02/202207:31EDGARCurrent Report Filing (8-k)
8/29/202208:00GLOBEIntercept Pharmaceuticals to Conduct One-on-One Meetings..
8/26/202216:02EDGARCurrent Report Filing (8-k)
8/22/202208:30TRMNAnalysts Offer Insights on Healthcare Companies:..
8/19/202207:30GLOBEIntercept Pharmaceuticals Announces Repurchase of..
8/18/202216:14EDGARStatement of Ownership (sc 13g)
8/18/202208:00GLOBEIntercept Pharmaceuticals to Participate in B. Riley’s PBC..
8/17/202216:02EDGARStatement of Changes in Beneficial Ownership (4)
8/16/202216:01EDGARCurrent Report Filing (8-k)
8/04/202223:45TRMNRobert W. Baird Keeps Their Buy Rating on Intercept Pharma..
8/04/202200:15TRMNAnalysts’ Opinions Are Mixed on These Healthcare Stocks:..
8/03/202216:15TRMNIntercept Pharma (ICPT) Receives a Buy from Needham
8/03/202216:04EDGARQuarterly Report (10-q)
8/03/202216:03EDGARStatement of Changes in Beneficial Ownership (4)
8/03/202207:02EDGARCurrent Report Filing (8-k)
8/03/202207:00GLOBEIntercept Pharmaceuticals Reports Second Quarter 2022..
7/27/202208:00GLOBEIntercept to Announce Second Quarter 2022 Financial Results..
7/26/202207:31EDGARCurrent Report Filing (8-k)
7/14/202210:15TRMNAnalysts Conflicted on These Healthcare Names: Intercept..
7/13/202216:02EDGARStatement of Changes in Beneficial Ownership (4)
7/11/202223:35TRMNRobert W. Baird Keeps a Buy Rating on Intercept Pharma..
7/08/202222:07TRMNRBC Capital Sticks to Their Hold Rating for Intercept Pharma..
7/08/202208:36TRMNAnalysts Have Conflicting Sentiments on These Healthcare..
7/08/202205:25TRMNNeedham Reaffirms Their Buy Rating on Intercept Pharma..
7/07/202213:15TRMNJMP Securities Keeps a Hold Rating on Intercept Pharma..
7/07/202212:37TRMNB.Riley Financial Sticks to Their Buy Rating for Intercept..
7/07/202208:29DJNIntercept Reports More Positive Phase 3 Data From NASH Study
7/07/202207:30GLOBEIntercept Announces Positive Data in Fibrosis due to NASH..
7/01/202216:47EDGARCurrent Report Filing (8-k)
7/01/202216:01GLOBEIntercept Announces Closing of Transaction with Advanz..


Your Recent History
NASDAQ
ICPT
Intercept ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now